NVAX250425P8500
- 1.01
- -1.62-61.60%
Novavax Newsroom
Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains?
Novavax Inc. Stock Rallies 19.5%, Outperforms Competitors
Sector Update: Health Care Stocks Edge Up Late Afternoon
Sector Update: Health Care
Vertiv Earnings Beat, DOJ & Disney–fuboTV Deal, Novavax COVID Shot
$NVAX Stock Is up 17% Today. Here's What We See in Our Data.
Novavax Soars 25% Intraday as Pharma Firm Says Its COVID Vaccine Is 'Approvable'
Novavax Says Its COVID-19 Shot Is on Track for Full FDA Approval After Delay
Novavax Jumps 22% As FDA Requests More Info To Create Addl. Clinical Data For COVID-19 Vaccine BLA
Amphenol Posts Better-Than-Expected Results, Joins SAP, Tesla, Pegasystems And Other Big Stocks Moving Higher On Wednesday
Novavax Has Improved Clarity on Path Forward for Nuvaxovid, Says BofA
Novavax Stock Jumps on Positive FDA Discussions
Express News | Novavax Shares up 13.8% Premarket After Co Says Covid-19 Vaccine Is Approvable Based on Conversations With the US FDA
Novavax Believes Its Biologics License Application Is Approvable Based On Conversations With FDA As Of PDUFA Date On Apr. 1 And Through Today
Express News | Novavax Inc - FDA Requests Post Marketing Commitment for Additional Clinical Data for Its Covid-19 Vaccine
Express News | Novavax: "We Believe That Our Bla Is Approvable Based on Conversations With FDA, as of Our Pdufa Date on April 1 and Through Today"
Express News | Novavax Inc - to Engage With FDA to Address Pmc Request - SEC Filing
Latest Update on U.S. FDA BLA for Novavax's COVID-19 Vaccine
BofA Securities Maintains Novavax(NVAX.US) With Hold Rating, Maintains Target Price $10
Novavax Inc. Stock Underperforms Thursday When Compared To Competitors